Skip to main content

Health condition · Clinically reviewed

Malignant mesothelioma, from asbestos exposure to specialist treatment.

An aggressive, asbestos-linked cancer with a long latency period. Early specialist assessment shapes both treatment options and compensation claims.

Jump to treatment
A radiographer guides a patient onto the bed of an advanced 3 Tesla MRI scanner in a London imaging suite

Why trust this guide

  • 01

    Clinically reviewed

    Written by our editorial team and reviewed by a registered UK clinician before publication.

  • 02

    Sourced from guidance

    Checked against NICE, BTS and peer-reviewed sources you can see at the end.

  • 03

    Current for 2026

    Reflects modern UK guidance including immunotherapy, MDT pathways and compensation routes.

Key facts

Mesothelioma at a glance.

The essentials, in plain English - what it is, why asbestos matters, and how it's diagnosed and treated in the UK today.

  • What it is

    An aggressive cancer of the mesothelial lining - most often the pleura, occasionally the peritoneum, pericardium or tunica vaginalis.

  • Main cause

    Strongly linked to asbestos exposure, with a long latency of 20 to 50 years between exposure and diagnosis.

  • UK picture

    The UK has one of the highest incidence rates in the world, a legacy of historical industrial asbestos use.

  • Pleural form

    Around 90% of cases - chest pain, breathlessness, pleural effusion, weight loss and finger clubbing.

  • Diagnosis

    CT chest and thoracoscopic or VATS pleural biopsy with immunohistochemistry give the definitive diagnosis.

  • Care model

    Managed through specialist commissioned mesothelioma MDTs, with legal and compensation support alongside treatment.

Why this guide matters

A rare cancer with an uncommonly clear cause.

Mesothelioma is rare, but the UK sees more of it than almost anywhere else. The three points below shape everything else on this page.

  • Asbestos exposure is the key history

    Occupational or environmental asbestos exposure decades earlier is central to diagnosis - always worth mentioning, however distant it seems.

  • Biopsy confirms what imaging suggests

    CT scanning raises suspicion, but a thoracoscopic or VATS biopsy with immunohistochemistry is what actually confirms the diagnosis.

  • Treatment and compensation run together

    Chemotherapy, immunotherapy and selective surgery sit alongside Industrial Injuries Disablement Benefit and Diffuse Mesothelioma Payment Scheme claims - both matter from day one.

How the diagnosis is made

From exposure history to a confirmed diagnosis.

The steps a UK respiratory team or mesothelioma MDT will normally follow, in order - so you know what to expect and why.

  1. 01

    Assessing

    Occupational history

    A detailed asbestos exposure and latency history is the single most important clue - trades, sites, dates and duration all matter.

  2. 02

    Assessing

    Chest X-ray

    Often the first test - looks for pleural effusion or thickening that prompts further imaging.

  3. 03

    Assessing

    CT chest

    Defines pleural thickening and nodularity in more detail and is arranged through specialist commissioned imaging services.

  4. 04

    Confirming

    Pleural fluid cytology

    Fluid can be sampled if there is an effusion, though cytology alone is often non-diagnostic for mesothelioma.

  5. 05

    Confirming

    Thoracoscopic or VATS biopsy

    The definitive diagnostic step - a specialist commissioned tissue biopsy with immunohistochemistry (calretinin, WT1 and other markers) to distinguish mesothelioma from lung adenocarcinoma.

  6. 06

    Planning

    PET-CT staging

    A specialist commissioned scan that maps disease extent and guides whether surgery is a realistic option.

  7. 07

    Planning

    Mesothelioma MDT and support

    Case discussion at a specialist mesothelioma centre, alongside early advice on Industrial Injuries Disablement Benefit and the Diffuse Mesothelioma Payment Scheme.

Typical timeline: imaging to a confirmed diagnosis and MDT plan within a few weeks.

Symptoms

What mesothelioma actually looks like.

Pleural disease dominates the picture, but peritoneal mesothelioma presents quite differently. Here is the classic mix - and what should prompt urgent review.

  • Chest pain

    Persistent, often dull ache on one side of the chest - a common early pleural symptom.

  • Breathlessness

    Progressive shortness of breath, frequently linked to a build-up of pleural fluid.

  • Pleural effusion

    Fluid accumulating around the lung - often the finding that first prompts investigation.

  • Unexplained weight loss

    A general cancer symptom seen in both pleural and peritoneal disease.

  • Persistent cough

    A dry or irritating cough that does not settle, sometimes alongside breathlessness.

  • Finger clubbing

    A less common but recognised sign of chronic pleural disease.

  • Abdominal pain and ascites

    The peritoneal form presents with abdominal swelling, pain and fluid rather than chest symptoms.

  • Red flag - bowel obstruction

    Peritoneal mesothelioma can cause bowel obstruction as disease advances - needs urgent assessment.

Treatment

How mesothelioma is treated in the UK.

Chemotherapy and immunotherapy for most patients, selective surgery for a fit few, and symptom control, legal support and MDT care running throughout.

  • Surgery

    Extrapleural pneumonectomy or pleurectomy/decortication for carefully selected, fit, early-stage patients - specialist commissioned thoracic surgery with a debated survival benefit.

  • Chemotherapy

    Pemetrexed plus cisplatin or carboplatin remains the first-line standard of care for most patients.

  • Immunotherapy

    Nivolumab plus ipilimumab, established in the CheckMate 743 trial, is an approved specialist commissioned first-line option.

  • Radiotherapy

    Used for palliative symptom control, and selectively as prophylactic treatment to biopsy or drain tracts - specialist commissioned.

  • Pleurodesis or IPC

    Pleurodesis or an indwelling pleural catheter controls recurrent effusion symptoms - specialist commissioned.

  • Palliative care

    Symptom management and psychological support given the generally poor prognosis - specialist commissioned and offered early, not just at the end.

  • Legal and compensation support

    Mesothelioma UK and Asbestos Victims Support help with Industrial Injuries Disablement Benefit and Diffuse Mesothelioma Payment Scheme claims - specialist practical support.

  • MDT-led care

    Specialist commissioned thoracic oncology multidisciplinary teams, working alongside Mesothelioma UK, coordinate the whole pathway.

What this guide is based on

The sources behind every claim on this page.

UK national guidance, specialist society standards and pivotal trial evidence, current at the time of last review.

Key references

Guidelines and standards we relied on.

A quiet reminder

This guide is for information, not medical advice.

Your respiratory physician or oncology team knows your history and scans and can tell you which parts apply to you. If in doubt, get seen.

  • NICE. Mesothelioma: diagnosis and management (NG158).

  • British Thoracic Society (BTS). Guideline for the investigation and management of malignant pleural mesothelioma.

  • Baas P, et al. First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743).

  • Mesothelioma UK. Patient and family support, and guidance on the Diffuse Mesothelioma Payment Scheme.

Red flags

When mesothelioma needs urgent attention.

A history of asbestos exposure changes how any new chest or abdominal symptom should be treated. These are the situations that need prompt specialist input.

  • New unexplained pleural effusion

    Any unexplained fluid around the lung in someone with possible asbestos exposure needs prompt chest imaging and specialist referral.

  • History of asbestos exposure

    Even distant or seemingly minor exposure decades ago is relevant - always mention it to your doctor if you develop chest or abdominal symptoms.

  • Bowel obstruction

    A feature of advancing peritoneal mesothelioma - abdominal pain with vomiting or absolute constipation needs urgent hospital assessment.

  • Rapid breathlessness

    Fast-worsening breathlessness, especially with chest pain, warrants same-day medical review.

  • Significant unexplained weight loss

    Combined with chest or abdominal symptoms, this should prompt urgent investigation rather than watchful waiting.

  • Delayed diagnosis risk

    Symptoms can be mistaken for more common chest conditions - persistent or worsening symptoms deserve a second look if not improving as expected.

  • Pericardial or testicular involvement

    The rarer pericardial and tunica vaginalis forms can present atypically with cardiac symptoms or a scrotal mass - both need specialist referral.

  • Missed compensation deadlines

    Industrial Injuries Disablement Benefit and Diffuse Mesothelioma Payment Scheme claims are time-sensitive - seek advice as soon as possible after diagnosis.

  • Psychological distress

    A mesothelioma diagnosis carries a heavy emotional burden - low mood or distress should be raised early with the MDT or GP.

Living with it

A serious diagnosis, with real support around it.

Four things that make the biggest difference after diagnosis - specialist nursing support, timely compensation claims, proactive symptom control and a coordinated MDT.

A quiet reminder

You do not have to navigate this alone.

Specialist nurses, legal advisers and your MDT exist precisely for this diagnosis - use them early rather than later.

  1. 01 Support

    Ask about Mesothelioma UK

    A dedicated specialist nurse service that supports patients and families through diagnosis, treatment and beyond.

  2. 02 Legal

    Start compensation claims early

    The Diffuse Mesothelioma Payment Scheme and Industrial Injuries Disablement Benefit have their own timelines - get advice as soon as you can.

  3. 03 Symptoms

    Stay ahead of breathlessness

    Pleurodesis or an indwelling pleural catheter can make a real difference to day-to-day comfort if effusions recur.

  4. 04 MDT

    Lean on the specialist team

    A mesothelioma MDT coordinates surgery, oncology, palliative care and psychological support so you are not managing this alone.

Frequently asked

Everything we get asked about mesothelioma.

Quick answers on asbestos links, diagnosis, treatment options and compensation.

  • What is malignant mesothelioma?

    An aggressive cancer of the mesothelial lining that covers the lungs, abdomen, heart or testes. The pleural form, affecting the lining around the lungs, accounts for around 90% of cases. It is strongly linked to asbestos exposure.

  • How is mesothelioma linked to asbestos?

    Inhaled or ingested asbestos fibres cause chronic irritation and mutation in mesothelial cells, typically over a very long latency period of 20 to 50 years. The UK has one of the highest incidence rates globally because of historical industrial asbestos use.

  • What tests confirm the diagnosis?

    A CT chest scan usually shows pleural thickening or nodularity, but the definitive diagnosis comes from a thoracoscopic or VATS pleural biopsy, examined with immunohistochemistry markers such as calretinin and WT1 to distinguish it from lung adenocarcinoma.

  • Is surgery an option?

    Surgery, either extrapleural pneumonectomy or pleurectomy/decortication, is reserved for carefully selected, fit patients with early-stage disease. It is specialist commissioned thoracic surgery and its survival benefit remains debated, so it is discussed case by case at the MDT.

  • What is the standard drug treatment?

    Pemetrexed combined with cisplatin or carboplatin is the established first-line chemotherapy. Nivolumab plus ipilimumab, an immunotherapy combination, is now an approved specialist commissioned first-line alternative, based on the CheckMate 743 trial.

  • Can I claim compensation for asbestos exposure?

    Yes. Mesothelioma is a recognised industrial disease, and most patients can claim Industrial Injuries Disablement Benefit and apply to the Diffuse Mesothelioma Payment Scheme. Mesothelioma UK and Asbestos Victims Support can guide you through both processes.

Related content

Keep reading.

Pulse Healthcare concierge

Send us your enquiry

A concierge service for UK private healthcare. We match you with the best vetted clinics and consultants in our network - they then contact you directly.

So we can match you to the right clinician close to you.

We reply to every enquiry within 24 hours (Mon–Fri). Confidential - your details are never shared outside our vetted consultant network.